- Home
- CMBM vs CTXR Comparison
CMBM vs CTXR Comparison
Compare CMBM & CTXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMBM
- CTXR
- Stock Information
- Founded
- CMBM 2011
- CTXR 2007
- Country
- CMBM United States
- CTXR United States
- Employees
- CMBM N/A
- CTXR N/A
- Industry
- CMBM Radio And Television Broadcasting And Communications Equipment
- CTXR Biotechnology: Pharmaceutical Preparations
- Sector
- CMBM Technology
- CTXR Health Care
- Exchange
- CMBM Nasdaq
- CTXR Nasdaq
- Market Cap
- CMBM 27.1M
- CTXR 28.4M
- IPO Year
- CMBM 2019
- CTXR N/A
- Fundamental
- Price
- CMBM $1.03
- CTXR $3.30
- Analyst Decision
- CMBM Strong Buy
- CTXR Strong Buy
- Analyst Count
- CMBM 3
- CTXR 2
- Target Price
- CMBM $5.50
- CTXR $54.50
- AVG Volume (30 Days)
- CMBM 490.3K
- CTXR 185.5K
- Earning Date
- CMBM 02-13-2025
- CTXR 02-12-2025
- Dividend Yield
- CMBM N/A
- CTXR N/A
- EPS Growth
- CMBM N/A
- CTXR N/A
- EPS
- CMBM N/A
- CTXR N/A
- Revenue
- CMBM $172,215,000.00
- CTXR N/A
- Revenue This Year
- CMBM N/A
- CTXR N/A
- Revenue Next Year
- CMBM $16.49
- CTXR $216.25
- P/E Ratio
- CMBM N/A
- CTXR N/A
- Revenue Growth
- CMBM N/A
- CTXR N/A
- 52 Week Low
- CMBM $0.64
- CTXR $2.44
- 52 Week High
- CMBM $4.92
- CTXR $26.75
- Technical
- Relative Strength Index (RSI)
- CMBM 56.37
- CTXR 41.54
- Support Level
- CMBM $0.87
- CTXR $3.70
- Resistance Level
- CMBM $1.19
- CTXR $4.43
- Average True Range (ATR)
- CMBM 0.14
- CTXR 0.54
- MACD
- CMBM 0.03
- CTXR 0.06
- Stochastic Oscillator
- CMBM 70.91
- CTXR 6.03
About CMBM Cambium Networks Corporation
Cambium Networks Corp provides wireless broadband networking infrastructure solutions for network operators, including medium-sized wireless Internet service providers, enterprises, and government agencies. The company geographically operates in North America; Europe, Middle East and Africa; Caribbean and Latin America; and Asia Pacific. It derives maximum revenue from North America.
About CTXR Citius Pharmaceuticals Inc.
Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. It is currently advancing four proprietary product candidates: LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma . Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections; Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries; Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; NoveCite, a mesenchymal stem cell therapy for the treatment of acute respiratory distress syndrome.